<p>Cyndeo Wealth Partners LLC 在最近向证券交易委员会提交的文件中表示，在第三季度减少了对 HCA Healthcare, Inc. (NYSE:HCA - 免费报告) 的持股比例，降幅为 58.7%。该公司在此期间出售了 14,376 股后，持有 10,099 股 HCA 的股票。Cyndeo Wealth Partners LLC 在 HCA Healthcare 的持股在最近的报告期末价值为 4,304,000 美元。</p>
<ul>
<li>MarketBeat 周回顾 – 07/28 - 08/01</li>
</ul>
<p>其他一些大型投资者也对 HCA 的持仓进行了调整。Brighton Jones LLC 在第四季度购买了 HCA Healthcare 的新头寸，价值约为 1,021,000 美元。T. Rowe Price Investment Management Inc. 在第一季度将其在 HCA Healthcare 的持仓提高了 13.1%。T. Rowe Price Investment Management Inc. 现在拥有 2,546 股该公司的股票，价值 880,000 美元，此前在此期间又购买了 295 股。CW Advisors LLC 在第一季度将其在 HCA Healthcare 的持股增加了 22.9%。CW Advisors LLC 现在拥有 1,277 股该公司的股票，价值 441,000 美元，此前在上个季度又收购了 238 股。Norinchukin Bank The 在第一季度将其在 HCA Healthcare 的持仓提高了 10.7%。Norinchukin Bank The 现在拥有 7,966 股该公司的股票，价值 2,753,000 美元，此前在上个季度又购买了 770 股。最后，Ameriprise Financial Inc. 在第一季度将其在 HCA Healthcare 的持股增加了 10.2%。Ameriprise Financial Inc. 现在拥有 483,564 股该公司的股票，价值 167,094,000 美元，此前在此期间又购买了 44,884 股。机构投资者和对冲基金持有该公司 62.73% 的股票。</p>
<p>获取 <strong>HCA Healthcare</strong> 警报：</p>
<h2>HCA Healthcare 股价上涨 1.3%</h2>
<p>HCA Healthcare 股票周五开盘价为 472.69 美元。该公司的市值为 1,078.7 亿美元，市盈率为 18.27，PEG 比率为 1.40，贝塔值为 1.36。HCA Healthcare, Inc. 的一年低点为 289.98 美元，一年高点为 520.00 美元。该公司的 50 日简单移动平均线为 470.12 美元，200 日简单移动平均线为 417.03 美元。</p>
<ul>
<li>HCA Healthcare 能否振兴市场最疲软的行业？</li>
</ul>
<p>HCA Healthcare (NYSE:HCA - 获取免费报告) 最近于 10 月 24 日发布了季度财报。公司报告本季度每股收益 (EPS) 为 6.96 美元，超出分析师一致预期的 5.64 美元，超出幅度为 1.32 美元。HCA Healthcare 的净利润率为 8.53%，股本回报率为 -792.25%。公司本季度的收入为 191.6 亿美元，而分析师预期为 185.5 亿美元。在去年同期，公司每股收益为 4.90 美元。与去年同期相比，公司的季度收入增长了 9.6%。HCA Healthcare 已设定 2025 财年的每股收益指导范围为 27.000-28.000。整体来看，研究分析师预测 HCA Healthcare, Inc. 本年度每股收益将为 24.98 美元。</p>
<h2>HCA Healthcare 分红公告</h2>
<p>该公司最近还披露了季度分红，将于 12 月 29 日星期一支付。12 月 15 日的股东将获得 0.72 美元的分红。这代表着年化分红为 2.88 美元，分红收益率为 0.6%。该分红的除息日期为 12 月 15 日星期一。HCA Healthcare 的分红支付比率目前为 11.13%。</p>
<h2>分析师评级上调与下调</h2>
<ul>
<li>综合医疗股票能否在公开市场上成功？</li>
</ul>
<p>几位股票分析师最近对该股票发表了评论。Jefferies Financial Group 将 HCA Healthcare 的目标价从 485.00 美元上调至 525.00 美元，并在 10 月 28 日的报告中给予该公司 &#34;买入&#34; 评级。Cowen 在 10 月 27 日的研究报告中重申了对 HCA Healthcare 的 &#34;买入&#34; 评级。Zacks Research 在 11 月 27 日的研究报告中将 HCA Healthcare 的评级从 &#34;强力买入&#34; 下调至 &#34;持有&#34;。加拿大皇家银行在周五的研究报告中将 HCA Healthcare 的目标价从 482.00 美元上调至 525.00 美元，并给予该公司 &#34;跑赢大盘&#34; 的评级。最后，瑞银集团在 10 月 27 日的报告中将 HCA Healthcare 的目标价从 495.00 美元上调至 525.00 美元，并给予该公司 &#34;买入&#34; 评级。十四位研究分析师对该股票给予了买入评级，九位给予了持有评级，一位给予了卖出评级。根据 MarketBeat 的数据，该股票目前的平均评级为 &#34;适度买入&#34;，平均目标价为 479.00 美元。</p>
<p><strong>阅读我们关于 HCA 的最新报告</strong></p>
<h2>HCA Healthcare 的内部交易</h2>
<p>在相关消息中，执行副总裁 Michael R. Mcalevey 于 11 月 5 日星期三出售了 3,892 股该公司的股票。股票以平均价格 473.79 美元出售，总交易额为 1,843,990.68 美元。交易完成后，该执行副总裁直接持有该公司 3,487 股股票，价值 1,652,105.73 美元。这代表着其持股比例减少了 52.74%。该交易已在向证券交易委员会提交的文件中披露，相关文件可通过此链接获取。公司内部人士持有该公司 1.30% 的股票。</p>
<h2>关于 HCA Healthcare</h2>
<p>(免费报告)</p>
<p>HCA Healthcare 是一家以盈利为目的的医疗设施运营商，总部位于田纳西州纳什维尔。公司成立于 1968 年，拥有并运营一系列医院及相关医疗设施，并通过有机扩张和收购发展成为大型住院和门诊服务提供商。</p>
<p>公司的核心业务包括急救医院、独立外科和急救中心以及门诊诊所的运营。HCA 的服务涵盖住院护理、外科服务、急救医学、诊断影像和实验室检测，以及各种门诊和流动护理服务。</p>
<h2>推荐故事</h2>
<ul>
<li>五只我们认为比 HCA Healthcare 更好的股票</li>
<li>高分红房地产投资信托：它们是理想的多元化方式吗？</li>
<li>这三家银行在年末反弹，但这种趋势会持续吗？</li>
<li>通过这些分红之王渡过衰退</li>
<li>三只飙升的股票刚刚获得标准普尔 500 的最终认可</li>
<li>稀释每股收益（Diluted EPS）是什么？</li>
<li>这只 ETF 在美联储降息后获得了重大顺风</li>
</ul>
<p><strong>想看看其他对 HCA 持有的对冲基金吗？</strong> 请访问 HoldingsChannel.com，获取 HCA Healthcare, Inc.（NYSE:HCA - 免费报告）的最新 13F 文件和内部交易信息。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUhDQQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUhDQQ"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1000 美元在 HCA Healthcare 吗？</h2>
<p>在考虑 HCA Healthcare 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 HCA Healthcare 并不在名单上。</p>
<p>虽然 HCA Healthcare 目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

HCA控股

<p>Cyndeo Wealth Partners LLC 在第三季度减少了对 HCA Healthcare 的持股比例，降幅为 58.7%，目前持有 10,099 股，价值 430 万美元。HCA 的股票开盘价为 472.69 美元，市值为 1078.7 亿美元。该公司报告第三季度每股收益为 6.96 美元，超出预期，并宣布每季度派息 0.72 美元。分析师的评级意见不一，大多数分析师推荐买入</p>

<p>Cyndeo Wealth Partners LLC lessened its stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 58.7% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 10,099 shares of the company's stock after selling 14,376 shares during the period. Cyndeo Wealth Partners LLC's holdings in HCA Healthcare were worth $4,304,000 at the end of the most recent reporting period.</p>
<div class="lb-trans"><p>Cyndeo Wealth Partners LLC 在最近向证券交易委员会提交的文件中表示，在第三季度减少了对 HCA Healthcare, Inc. (NYSE:HCA - 免费报告) 的持股比例，降幅为 58.7%。该公司在此期间出售了 14,376 股后，持有 10,099 股 HCA 的股票。Cyndeo Wealth Partners LLC 在 HCA Healthcare 的持股在最近的报告期末价值为 4,304,000 美元。</p>
</div><ul>
<li>MarketBeat Week in Review – 07/28 - 08/01</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 周回顾 – 07/28 - 08/01</li>
</ul>
</div><p>A number of other large investors have also made changes to their positions in HCA. Brighton Jones LLC purchased a new position in HCA Healthcare during the 4th quarter worth approximately $1,021,000. T. Rowe Price Investment Management Inc. raised its position in HCA Healthcare by 13.1% during the first quarter. T. Rowe Price Investment Management Inc. now owns 2,546 shares of the company's stock valued at $880,000 after buying an additional 295 shares during the period. CW Advisors LLC grew its stake in HCA Healthcare by 22.9% during the 1st quarter. CW Advisors LLC now owns 1,277 shares of the company's stock valued at $441,000 after acquiring an additional 238 shares in the last quarter. Norinchukin Bank The lifted its position in shares of HCA Healthcare by 10.7% in the first quarter. Norinchukin Bank The now owns 7,966 shares of the company's stock worth $2,753,000 after purchasing an additional 770 shares in the last quarter. Finally, Ameriprise Financial Inc. increased its stake in HCA Healthcare by 10.2% in the 1st quarter. Ameriprise Financial Inc. now owns 483,564 shares of the company's stock valued at $167,094,000 after buying an additional 44,884 shares during the period. Institutional investors and hedge funds own 62.73% of the company's stock.</p>
<div class="lb-trans"><p>其他一些大型投资者也对 HCA 的持仓进行了调整。Brighton Jones LLC 在第四季度购买了 HCA Healthcare 的新头寸，价值约为 1,021,000 美元。T. Rowe Price Investment Management Inc. 在第一季度将其在 HCA Healthcare 的持仓提高了 13.1%。T. Rowe Price Investment Management Inc. 现在拥有 2,546 股该公司的股票，价值 880,000 美元，此前在此期间又购买了 295 股。CW Advisors LLC 在第一季度将其在 HCA Healthcare 的持股增加了 22.9%。CW Advisors LLC 现在拥有 1,277 股该公司的股票，价值 441,000 美元，此前在上个季度又收购了 238 股。Norinchukin Bank The 在第一季度将其在 HCA Healthcare 的持仓提高了 10.7%。Norinchukin Bank The 现在拥有 7,966 股该公司的股票，价值 2,753,000 美元，此前在上个季度又购买了 770 股。最后，Ameriprise Financial Inc. 在第一季度将其在 HCA Healthcare 的持股增加了 10.2%。Ameriprise Financial Inc. 现在拥有 483,564 股该公司的股票，价值 167,094,000 美元，此前在此期间又购买了 44,884 股。机构投资者和对冲基金持有该公司 62.73% 的股票。</p>
</div><p>Get <strong>HCA Healthcare</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>HCA Healthcare</strong> 警报：</p>
</div><h2>HCA Healthcare Trading Up 1.3%</h2>
<div class="lb-trans"><h2>HCA Healthcare 股价上涨 1.3%</h2>
</div><p>Shares of HCA Healthcare stock opened at $472.69 on Friday. The stock has a market capitalization of $107.87 billion, a price-to-earnings ratio of 18.27, a PEG ratio of 1.40 and a beta of 1.36. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $520.00. The firm has a fifty day simple moving average of $470.12 and a 200-day simple moving average of $417.03.</p>
<div class="lb-trans"><p>HCA Healthcare 股票周五开盘价为 472.69 美元。该公司的市值为 1,078.7 亿美元，市盈率为 18.27，PEG 比率为 1.40，贝塔值为 1.36。HCA Healthcare, Inc. 的一年低点为 289.98 美元，一年高点为 520.00 美元。该公司的 50 日简单移动平均线为 470.12 美元，200 日简单移动平均线为 417.03 美元。</p>
</div><ul>
<li>Can HCA Healthcare Revive the Market’s Weakest Sector?</li>
</ul>
<div class="lb-trans"><ul>
<li>HCA Healthcare 能否振兴市场最疲软的行业？</li>
</ul>
</div><p>HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings results on Friday, October 24th. The company reported $6.96 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $5.64 by $1.32. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. The company had revenue of $19.16 billion during the quarter, compared to analysts' expectations of $18.55 billion. During the same period in the prior year, the company earned $4.90 earnings per share. The business's quarterly revenue was up 9.6% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. As a group, research analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.</p>
<div class="lb-trans"><p>HCA Healthcare (NYSE:HCA - 获取免费报告) 最近于 10 月 24 日发布了季度财报。公司报告本季度每股收益 (EPS) 为 6.96 美元，超出分析师一致预期的 5.64 美元，超出幅度为 1.32 美元。HCA Healthcare 的净利润率为 8.53%，股本回报率为 -792.25%。公司本季度的收入为 191.6 亿美元，而分析师预期为 185.5 亿美元。在去年同期，公司每股收益为 4.90 美元。与去年同期相比，公司的季度收入增长了 9.6%。HCA Healthcare 已设定 2025 财年的每股收益指导范围为 27.000-28.000。整体来看，研究分析师预测 HCA Healthcare, Inc. 本年度每股收益将为 24.98 美元。</p>
</div><h2>HCA Healthcare Dividend Announcement</h2>
<div class="lb-trans"><h2>HCA Healthcare 分红公告</h2>
</div><p>The firm also recently disclosed a quarterly dividend, which will be paid on Monday, December 29th. Stockholders of record on Monday, December 15th will be given a $0.72 dividend. This represents a $2.88 annualized dividend and a dividend yield of 0.6%. The ex-dividend date of this dividend is Monday, December 15th. HCA Healthcare's dividend payout ratio is currently 11.13%.</p>
<div class="lb-trans"><p>该公司最近还披露了季度分红，将于 12 月 29 日星期一支付。12 月 15 日的股东将获得 0.72 美元的分红。这代表着年化分红为 2.88 美元，分红收益率为 0.6%。该分红的除息日期为 12 月 15 日星期一。HCA Healthcare 的分红支付比率目前为 11.13%。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析师评级上调与下调</h2>
</div><ul>
<li>Can Integrated Healthcare Stocks Succeed in Public Markets?</li>
</ul>
<div class="lb-trans"><ul>
<li>综合医疗股票能否在公开市场上成功？</li>
</ul>
</div><p>Several equities analysts have recently commented on the stock. Jefferies Financial Group boosted their price target on shares of HCA Healthcare from $485.00 to $525.00 and gave the company a &#34;buy&#34; rating in a report on Tuesday, October 28th. Cowen reaffirmed a &#34;buy&#34; rating on shares of HCA Healthcare in a research report on Monday, October 27th. Zacks Research cut HCA Healthcare from a &#34;strong-buy&#34; rating to a &#34;hold&#34; rating in a research note on Thursday, November 27th. Royal Bank Of Canada lifted their target price on shares of HCA Healthcare from $482.00 to $525.00 and gave the company an &#34;outperform&#34; rating in a research note on Friday. Finally, UBS Group raised their price target on shares of HCA Healthcare from $495.00 to $525.00 and gave the company a &#34;buy&#34; rating in a report on Monday, October 27th. Fourteen research analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock presently has an average rating of &#34;Moderate Buy&#34; and an average target price of $479.00.</p>
<div class="lb-trans"><p>几位股票分析师最近对该股票发表了评论。Jefferies Financial Group 将 HCA Healthcare 的目标价从 485.00 美元上调至 525.00 美元，并在 10 月 28 日的报告中给予该公司 &#34;买入&#34; 评级。Cowen 在 10 月 27 日的研究报告中重申了对 HCA Healthcare 的 &#34;买入&#34; 评级。Zacks Research 在 11 月 27 日的研究报告中将 HCA Healthcare 的评级从 &#34;强力买入&#34; 下调至 &#34;持有&#34;。加拿大皇家银行在周五的研究报告中将 HCA Healthcare 的目标价从 482.00 美元上调至 525.00 美元，并给予该公司 &#34;跑赢大盘&#34; 的评级。最后，瑞银集团在 10 月 27 日的报告中将 HCA Healthcare 的目标价从 495.00 美元上调至 525.00 美元，并给予该公司 &#34;买入&#34; 评级。十四位研究分析师对该股票给予了买入评级，九位给予了持有评级，一位给予了卖出评级。根据 MarketBeat 的数据，该股票目前的平均评级为 &#34;适度买入&#34;，平均目标价为 479.00 美元。</p>
</div><p><strong>Read Our Latest Report on HCA</strong></p>
<div class="lb-trans"><p><strong>阅读我们关于 HCA 的最新报告</strong></p>
</div><h2>Insider Transactions at HCA Healthcare</h2>
<div class="lb-trans"><h2>HCA Healthcare 的内部交易</h2>
</div><p>In related news, EVP Michael R. Mcalevey sold 3,892 shares of the company's stock in a transaction on Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the completion of the transaction, the executive vice president directly owned 3,487 shares in the company, valued at $1,652,105.73. This represents a 52.74% decrease in their position. The transaction was disclosed in a document filed with the Securities &amp; Exchange Commission, which is available through this link. Company insiders own 1.30% of the company's stock.</p>
<div class="lb-trans"><p>在相关消息中，执行副总裁 Michael R. Mcalevey 于 11 月 5 日星期三出售了 3,892 股该公司的股票。股票以平均价格 473.79 美元出售，总交易额为 1,843,990.68 美元。交易完成后，该执行副总裁直接持有该公司 3,487 股股票，价值 1,652,105.73 美元。这代表着其持股比例减少了 52.74%。该交易已在向证券交易委员会提交的文件中披露，相关文件可通过此链接获取。公司内部人士持有该公司 1.30% 的股票。</p>
</div><h2>About HCA Healthcare</h2>
<div class="lb-trans"><h2>关于 HCA Healthcare</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>(免费报告)</p>
</div><p>HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.</p>
<div class="lb-trans"><p>HCA Healthcare 是一家以盈利为目的的医疗设施运营商，总部位于田纳西州纳什维尔。公司成立于 1968 年，拥有并运营一系列医院及相关医疗设施，并通过有机扩张和收购发展成为大型住院和门诊服务提供商。</p>
</div><p>The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.</p>
<div class="lb-trans"><p>公司的核心业务包括急救医院、独立外科和急救中心以及门诊诊所的运营。HCA 的服务涵盖住院护理、外科服务、急救医学、诊断影像和实验室检测，以及各种门诊和流动护理服务。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推荐故事</h2>
</div><ul>
<li>Five stocks we like better than HCA Healthcare</li>
<li>High Dividend REITs: Are They an Ideal Way to Diversify?</li>
<li>These 3 Banks Are Rallying Into Year-End, But Will It Continue?</li>
<li>Ride Out The Recession With These Dividend Kings</li>
<li>3 Surging Stocks Just Got the Ultimate Stamp of Approval From the S&amp;P 500</li>
<li>What is diluted earnings per share (Diluted EPS)?</li>
<li>This ETF Caught a Major Tailwind After the Fed’s Rate Cut</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们认为比 HCA Healthcare 更好的股票</li>
<li>高分红房地产投资信托：它们是理想的多元化方式吗？</li>
<li>这三家银行在年末反弹，但这种趋势会持续吗？</li>
<li>通过这些分红之王渡过衰退</li>
<li>三只飙升的股票刚刚获得标准普尔 500 的最终认可</li>
<li>稀释每股收益（Diluted EPS）是什么？</li>
<li>这只 ETF 在美联储降息后获得了重大顺风</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding HCA?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他对 HCA 持有的对冲基金吗？</strong> 请访问 HoldingsChannel.com，获取 HCA Healthcare, Inc.（NYSE:HCA - 免费报告）的最新 13F 文件和内部交易信息。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUhDQQ" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=HCA"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in HCA Healthcare Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1000 美元在 HCA Healthcare 吗？</h2>
</div><p>Before you consider HCA Healthcare, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 HCA Healthcare 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 HCA Healthcare 并不在名单上。</p>
</div><p>While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 HCA Healthcare 目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Cyndeo Wealth Partners LLC 在 HCA Healthcare, Inc.持有价值 430 万美元的股票头寸